CVS Health Corp. has agreed to pay $37.76 million to resolve a False Claims Act lawsuit alleging that its pharmacies ...

For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...

CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

The success of semaglutide and tirzepatide is evident in their 2024 sales volumes and revenues, creating a clearer picture of ...

The jab is also known as Godzilla or Triple G, and authorities have warned that social media has become a “wild west” for ...

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted ...

Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...

Survey shows high death rates among children with Type 1 diabetes in India due to limited insulin access and late diagnosis.

Aher holds an insulin pen next to his father, Lual, in their home in Ariath, Aweil North, South Sudan. 2025 © Isaac Buay ...